Pfizer’s publication on Science Translational Medicine.
SMC announces that Pfizer has published the results of a study using STAM™ model in Science Translational Medicine.
Title: “Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis”